⚕ GalenOps CRO console
← 703 (USA)

703-1100

completed
Study: Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. Phase II · Site: 703 (USA) (Dr. Okafor) · consented 2013-03-13
Adverse events
9
Serious AEs
0
Open data queries
0
Luna dropout signal
–

Adverse events

moderate assessed 2026-08-18

Moderate APPLICATION SITE IRRITATION — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-04-05 (study day 24.0); relationship: PROBABLE

mild assessed 2026-08-18

Mild APPLICATION SITE IRRITATION — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-04-05 (study day 24.0); relationship: PROBABLE

mild assessed 2026-08-18

Mild APPLICATION SITE IRRITATION — outcome: RECOVERED/RESOLVED; onset 2013-04-05 (study day 24.0); relationship: PROBABLE

moderate assessed 2026-08-18

Moderate CATARACT OPERATION — outcome: RECOVERED/RESOLVED; onset 2013-04-25 (study day 44.0); relationship: NONE

moderate assessed 2026-08-18

Moderate OEDEMA PERIPHERAL — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-02-28 (study day -13.0); relationship: REMOTE

moderate assessed 2026-08-18

Moderate OEDEMA PERIPHERAL — outcome: RECOVERED/RESOLVED; onset 2013-02-28 (study day -13.0); relationship: REMOTE

mild assessed 2026-08-18

Mild OEDEMA PERIPHERAL — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-07-17 (study day 127.0); relationship: REMOTE

mild assessed 2026-08-18

Mild OEDEMA PERIPHERAL — outcome: RECOVERED/RESOLVED; onset 2013-07-17 (study day 127.0); relationship: REMOTE

moderate assessed 2026-08-18

Moderate UPPER RESPIRATORY TRACT INFECTION — outcome: RECOVERED/RESOLVED; onset 2013-05-27 (study day 76.0); relationship: REMOTE

Data queries

No data queries.

☾ Luna engagement

This participant doesn't use Luna.